Identification of Spiro-Fused [3-azabicyclo[3.1.0]hexane]oxindoles as Potential Antitumor Agents: Initial In Vitro Evaluation of Anti-Proliferative Effect and Actin Cytoskeleton Tr...

por Knyazev, Nickolay A., Shmakov, Stanislav V., Pechkovskaya, Sofya A., Filatov, Alexander S., Stepakov, Alexander V., Boitsov, Vitali M., Filatova, Natalia A.
Publicado 2021

Identification of Spiro-Fused Pyrrolo[3,4-a]pyrrolizines and Tryptanthrines as Potential Antitumor Agents: Synthesis and In Vitro Evaluation

por Latypova, Diana K., Shmakov, Stanislav V., Pechkovskaya, Sofya A., Filatov, Alexander S., Stepakov, Alexander V., Knyazev, Nickolay A., Boitsov, Vitali M.
Publicado 2021

Targeting ErbB3 Receptor in Cancer with Inhibitory Antibodies from Llama

por Eliseev, Igor E., Ukrainskaya, Valeria M., Yudenko, Anna N., Mikushina, Anna D., Shmakov, Stanislav V., Afremova, Anastasiya I., Ekimova, Viktoria M., Vronskaia, Anna A., Knyazev, Nickolay A., Shamova, Olga V.
Publicado 2021

Biological Evaluation of 3-Azaspiro[Bicyclo[3.1.0]Hexane-2,5′-Pyrimidines] as Potential Antitumor Agents

por Shmakov, Stanislav V., Latypova, Diana K., Shmakova, Tatiana V., Rubinshtein, Artem A., Chukin, Mark V., Zhuravskii, Sergei G., Knyazev, Nickolay A., Stepakov, Alexander V., Galagudza, Michael M., Boitsov, Vitali M.
Publicado 2022

Crystal structures of a llama VHH antibody BCD090-M2 targeting human ErbB3 receptor

por Eliseev, Igor E., Yudenko, Anna N., Vysochinskaya, Vera V., Svirina, Anna A., Evstratyeva, Anna V., Drozhzhachih, Maria S., Krendeleva, Elena A., Vladimirova, Anna K., Nemankin, Timofey A., Ekimova, Viktoria M., Ulitin, Andrey B., Lomovskaya, Maria I., Yakovlev, Pavel A., Bukatin, Anton S., Knyazev, Nickolay A., Moiseenko, Fedor V., Chakchir, Oleg B.
Publicado 2018